American Public Education vs Covista
APEI and CVSA side by side, both in services-educational services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How APEI and CVSA compare
Covista is the larger company, worth 5.3 times as much as American Public Education ($3.9B against $748M).
On earnings, Covista is cheaper: it trades at 16.1× trailing earnings, against 16.7× for American Public Education.
Covista grew revenue faster over the last twelve months (9.3% versus 2.9% for American Public Education).
Covista keeps more of each dollar of sales as profit, with a net margin of 12.8% compared with 6.8% at American Public Education.
Covista scores higher on the StockData Score (18 against 15 for American Public Education), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | APEI | CVSA |
|---|---|---|
| Size and price | ||
| Market cap | $748M | $3.9B |
| Share price | $40.88 | $118.17 |
| Change, 1 year | 16.9% | 22.0% |
| Change, 5 years | 72.6% | 286% |
| Beta (5Y) | 0.71 | 0.84 |
| Employees | 74 | 510 |
| StockData Score | ||
| Total score | 15 | 18 (better) |
| Valuation score | 3 | 3 |
| Growth score | 3 | 5 (better) |
| Performance score | 5 | 5 |
| Health score | 4 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 16.7× | 16.1× (better) |
| P/S | 1.1× (better) | 2.0× |
| P/B | 2.4× (better) | 2.8× |
| EV/EBITDA | 7.9× (better) | 10.6× |
| P/FCF | 13.3× | 11.1× (better) |
| PEG | – | 0.32 |
| FCF yield | 7.5% | 9.0% (better) |
| Fair value | $42.26 | $119.25 |
| Margin of safety | 3.3% (better) | 0.91% |
| Growth | ||
| Revenue growth (TTM) | 2.9% | 9.3% (better) |
| Revenue growth, 5Y average | 15.1% | 16.8% (better) |
| Net income growth (TTM) | 44.2% (better) | 1.8% |
| EPS growth (TTM) | 85.6% (better) | 9.6% |
| EPS growth, 5Y average | 1.7% | 38.9% (better) |
| Profitability | ||
| Gross margin | 56.2% | 57.4% (better) |
| Operating margin | 9.2% | 19.8% (better) |
| Net margin | 6.8% | 12.8% (better) |
| FCF margin | 8.4% | 17.7% (better) |
| Return on equity | 15.6% | 17.9% (better) |
| Return on invested capital | 26.4% (better) | 17.8% |
| Financial health | ||
| Debt / equity | 0.28 (better) | 0.35 |
| Net debt / EBITDA | −1.66 | 0.70 (better) |
| Interest coverage | – | 8.9× |
| Current ratio | 2.91 (better) | 0.81 |
| Altman Z-score | 3.93 | 4.12 (better) |
| Piotroski F-score | 7 | 8 (better) |
| Dividends and buybacks | ||
| Buyback yield | 3.1% | 8.0% (better) |
| Shareholder yield | 3.1% | 8.0% (better) |
| Ownership | ||
| Held by institutions | 107% | 103% |
| Held by insiders | 14.4% | 3.0% |
| Insider net buying, 12 months | −$22.0M | −$6.6M (better) |
| Short interest, % of float | 16.2% | 8.7% |
Go deeper
- APEI stock overview
- APEI income statement
- APEI valuation and score
- CVSA stock overview
- CVSA income statement
- CVSA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.